secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2026-04-14T23:59:59+00:00
Accession:  0001213900-26-043519
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics issues $437,500 convertible note to Keystone Capital Partners, 10% interest, due 2027
--------------------------------------------------------------------------------

- Issued to Keystone Capital Partners a convertible note with purchase price $350,000 and face value $437,500.
- Note bears interest at 10% per annum, matures April 9, 2027, with up to $1,000,000 total borrowing capacity.
- Conversion price is lesser of $0.05 or 80% of avg of 5 lowest intraday prices in 20 days prior to conversion.
- Beneficial ownership limitation of 4.99% applies; issuance exempt from registration under Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390026043519/0001213900-26-043519-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390026043519/ea0286319-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-043519

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer